Bill & Melinda Gates Foundation Bio N Tech Se Transaction History
Bill & Melinda Gates Foundation
- $43.5 Million
- Q3 2024
A detailed history of Bill & Melinda Gates Foundation transactions in Bio N Tech Se stock. As of the latest transaction made, Bill & Melinda Gates Foundation holds 148,674 shares of BNTX stock, worth $17 Million. This represents 40.59% of its overall portfolio holdings.
Number of Shares
148,674
Previous 148,674
-0.0%
Holding current value
$17 Million
Previous $11.9 Million
47.8%
% of portfolio
40.59%
Previous 29.71%
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$948 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$515 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$498 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$216 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$206 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...